SkinHealth Systems Inc. (SKIN) Current Ratio
- Current ratio · latest quarter: Value 1.76×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.76× | Current assets / current liabilities. $295.24M ÷ $168.20M ≈ 1.76× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 295.24M USD | Assets, Current |
| Current obligations | 168.20M USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 17.64M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 46.84M USD | Inventory, Net |
| Payables | 16.05M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $295.24M | $168.20M | (m) | (m) | $17.64M | $46.84M | $16.05M | (m) | 1.76× |
| 2026-03-31 | $277.69M | $155.20M | (m) | (m) | $18.61M | $47.69M | $15.88M | (m) | 1.79× |
| 2025-12-31 | $309.52M | $186.28M | (m) | (m) | $21.74M | $48.01M | $15.63M | (m) | 1.66× |
| 2025-09-30 | $308.37M | $61.90M | (m) | (m) | $22.21M | $56.15M | $17.29M | (m) | 4.98× |
| 2025-06-30 | $306.11M | $59.44M | (m) | (m) | $25.05M | $59.19M | $22.98M | (m) | 5.15× |
| 2025-03-31 | $469.37M | $62.80M | (m) | (m) | $23.26M | $65.63M | $23.14M | (m) | 7.47× |
| 2024-12-31 | $477.12M | $68.15M | (m) | (m) | $27.64M | $69.11M | $21.94M | (m) | 7.00× |
| 2024-09-30 | $485.05M | $73.95M | (m) | (m) | $36.28M | $73.44M | $23.08M | (m) | 6.56× |
| 2024-06-30 | $489.63M | $75.43M | (m) | (m) | $41.41M | $77.14M | $26.69M | (m) | 6.49× |
| 2024-03-31 | $614.82M | $93.57M | (m) | (m) | $47.67M | $95.72M | $37.31M | (m) | 6.57× |
| 2023-12-31 | $698.25M | $115.01M | (m) | (m) | $54.70M | $91.32M | $44.77M | (m) | 6.07× |
| 2023-09-30 | $738.01M | $125.88M | $559.44M | (m) | $66.81M | $74.88M | $35.88M | (m) | 5.86× |
| 2023-06-30 | $767.94M | $82.79M | $549.73M | (m) | $74.63M | $107.00M | $29.38M | (m) | 9.28× |
| 2023-03-31 | $748.53M | $72.33M | $532.28M | (m) | $70.80M | $122.08M | $34.33M | (m) | 10.35× |
| 2022-12-31 | $783.27M | $71.71M | $568.20M | (m) | $76.49M | $109.66M | $28.47M | (m) | 10.92× |
| 2022-09-30 | $892.43M | $76.44M | $684.21M | (m) | $83.98M | $101.71M | $32.58M | (m) | 11.68× |
| 2022-06-30 | $995.76M | $87.06M | $820.97M | (m) | $79.92M | $73.53M | $36.83M | (m) | 11.44× |
| 2022-03-31 | $982.39M | $68.93M | $859.24M | (m) | $60.77M | $47.03M | $26.96M | (m) | 14.25× |
| 2021-12-31 | $1.00B | $76.44M | $901.89M | (m) | $46.82M | $35.26M | $29.05M | (m) | 13.09× |
| 2021-09-30 | $797.80M | $49.47M | $718.62M | (m) | $38.39M | $28.11M | $18.12M | (m) | 16.13× |
| 2021-06-30 | $174.44M | $39.49M | $101.47M | (m) | $40.13M | $23.76M | $17.33M | (m) | 4.42× |
| 2021-03-31 | $3.35M | $813.47K | $2.75M | (m) | (m) | (m) | (m) | (m) | 4.12× |
| 2020-12-31 | $59.09M | $30.93M | $9.49M | (m) | $18.58M | $23.20M | $18.48M | (m) | 1.91× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |